Skip to main content

Vittoria Biotherapeutics

Philadelphia, United States

Vittoria Biotherapeutics is a gene-edited cell therapeutics company.

$15.0M raised
Nov 2023
Venture - Series Unknown

Top Investors

SV Health InvestorsAgent CapitalBioAdvanceUniversity of PennsylvaniaNYBC Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vittoria Biotherapeutics

How much funding has Vittoria Biotherapeutics raised?
Vittoria Biotherapeutics has raised $15.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2023.
Who are Vittoria Biotherapeutics's investors?
Vittoria Biotherapeutics's investors include SV Health Investors, Agent Capital, BioAdvance, University of Pennsylvania, NYBC Ventures.
Where is Vittoria Biotherapeutics headquartered?
Vittoria Biotherapeutics is headquartered in Philadelphia, United States.
What does Vittoria Biotherapeutics do?
Vittoria Biotherapeutics is a gene-edited cell therapeutics company.
What stage is Vittoria Biotherapeutics at?
Vittoria Biotherapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Vittoria Biotherapeutics — Funding & Investors." VCBacked, November 13, 2023, https://www.vcbacked.co/company/vittoria-biotherapeutics. Accessed June 4, 2026.
APA
VCBacked. (2023). Vittoria Biotherapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/vittoria-biotherapeutics
Wikipedia (cite web)
{{cite web |title=Vittoria Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vittoria-biotherapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .